Strategic Buyer or Private Equity: What Each One Actually Buys, and What It Costs You
A founder I worked with had two live offers on a specialty manufacturing business doing a little under four million of adjusted EBITDA. A competitor three states away offered twenty-six million, all cash at close, with a six month transition and then he was free. A private equity firm offered twenty-nine and a half, of which twenty-two was cash, three and a half was rollover into the new holding company, and four was an earnout tied to two years of gross margin. He looked at the two numbers, saw three and a half million of difference, and told me the choice was obvious. It was not obvious. It was two completely different transactions that happened to be printed on similar paper, and the right answer depended on things he had not thought about yet.
The thing founders miss is that a strategic buyer and a financial buyer are not competing to buy the same asset. They are underwriting different things. A strategic buyer is buying your business as an input to a business it already owns. It is asking what your customers, your capacity, your territory, your people, or your product line are worth once they sit inside its existing platform. A private equity buyer is buying a standalone cash flow that it intends to grow and sell again in four to six years. It is asking whether the company can carry debt, whether the earnings are durable without you, and whether there is a credible story for the next owner. Those two questions produce different numbers, different structures, and very different lives for you after the closing dinner.
Start with price, because that is where founders start anyway. In the current cycle, sponsor pricing in the lower middle market has generally been running ahead of strategic pricing on comparable assets, which surprises people who grew up on the old rule that strategics always pay more. The reason is capital. There is an enormous amount of committed private equity capital that has to be deployed, and competition among sponsors for clean lower middle market assets has been intense. The old rule was never really about willingness anyway. It was about synergies. A strategic can pay above the standalone value of your business when it can capture something that does not appear in your income statement, meaning cost it can remove, revenue it can sell into your customers, a market it can enter years faster, or a team it cannot hire. When those synergies are real, a strategic can beat any sponsor. When they are thin or speculative, the strategic is bidding against its own discipline and usually loses.
So the first useful question is not which type pays more in general. It is whether there exists a specific acquirer for whom your business is worth more inside their walls than it is on its own, and whether that acquirer knows it. That is a research question with a real answer, and it is answerable before you go to market. If two or three credible strategics exist and the synergy case is concrete, you want them in the process. If the honest answer is that nobody gets a step change from owning you, then you are selling a standalone cash flow, which means you are selling to sponsors, and you should build the entire preparation year around what sponsors underwrite.
The second difference is the currency. Strategic offers in this market skew toward cash at close, because a corporate acquirer with a balance sheet does not need to leave money on the table to align you. Sponsor offers skew toward a mix, because alignment is the whole model. That mix usually contains rollover equity and often contains an earnout, both of which are ways of paying you later and conditionally. The headline number on a sponsor term sheet is therefore not comparable to the headline number on a strategic term sheet without doing the arithmetic. Twenty-nine and a half million with seven and a half million at risk is not larger than twenty-six million guaranteed until you attach probabilities you can actually defend. I walked through how to do that arithmetic line by line in the equity value bridge, and the rollover piece specifically in rollover equity is a second deal most founders never negotiate.
The third difference, and the one founders underweight most severely, is what happens to you and to the company afterward. A strategic acquisition usually means integration. Your systems get migrated, your back office gets absorbed, your brand may or may not survive, and a meaningful share of your team becomes redundant because the acquirer already has those functions. That is not a criticism. It is the source of the synergy that justified the price. But if you told your controller of eleven years that everything would be fine, you should understand what you are signing. A sponsor recapitalization usually keeps the company intact as a platform, keeps the team, and keeps you in a seat for a few years with a board you now report to. That is a different kind of hard. You go from owning the company to running it for someone else, with a monthly reporting package and a debt covenant you did not previously have.
There is also a confidentiality asymmetry that almost never gets discussed and occasionally decides the whole thing. Running a process with strategics means putting your customer list, your pricing, your margins, and your churn in front of your direct competitors. Most of them are honorable and most processes are handled correctly, with staged disclosure and clean team arrangements. But the risk is not zero, the information does not come back, and the downside if the deal dies is asymmetric because that competitor now knows exactly what you charge your top ten accounts. Sponsors do not carry that risk in the same way. When we stage a process that includes direct competitors, we hold the most sensitive material back until very late and we make the release conditional on a real commitment, and I would tell any founder to insist on that.
Diligence feels different too. Sponsors run a heavier, more formal process, because they are borrowing money and their lender has its own diligence requirements sitting behind theirs. Expect a quality of earnings engagement, a formal management presentation, and a lot of database level financial analysis. Strategics often run a lighter financial process and a much heavier commercial and operational one, because they already understand the industry and what they need to know is whether your customers will stay and whether your operations will bolt on. Neither is easier. They just fail in different places, and the preparation that satisfies one does not automatically satisfy the other.
All of this is why I keep pushing founders to make the buyer lane decision before the process rather than during it. Nearly everything you would do in a preparation year has a different priority order depending on which lane you are in. If you are selling to sponsors, the single highest value work is proving the business runs without you, because owner dependency is priced directly into a sponsor model and I have written about how sharply in the owner dependency discount. If you are selling to a strategic, the highest value work is documenting the synergy case in terms their corporate development team can defend internally, because the number you get is a function of how much of that case they believe on the day the deal goes to their investment committee. Same company, same year of effort, different work.
The Cordis Institute working paper The Buyer Lane Preparation Map, published at doi.org/10.2139/ssrn.6735844, exists because of exactly this problem. Founders prepare generically, against an imagined average buyer who does not exist, and then meet a specific buyer with a specific underwriting model that tests things the preparation never touched. The companion preparation gap study of eighty-nine lower middle market transactions, at doi.org/10.2139/ssrn.6515478, found that sixty-eight percent of deals saw material adjustments after the letter of intent, with a median compression of nine point eight percent against the LOI number. A large share of that compression is not fraud or surprise. It is a buyer discovering that the business was prepared for a different question than the one it is asking.
One more practical note on structure. If you end up with a sponsor, the tax structure that makes rollover equity work properly is not automatic and it is decided in the letter of intent, not later. I covered that in asset sale or stock sale. A founder who takes rollover without the right structure underneath it can end up paying tax today on money he will not see for five years, which is a bad way to learn a lesson about paragraph ordering.
So how did the manufacturing founder decide. He priced the earnout at about half, because the gross margin target assumed a raw material environment he did not control, and he valued the rollover at a real but discounted number rather than at face. That put the two offers within a few hundred thousand dollars of each other on an honest expected basis. Then he stopped doing arithmetic and asked what he wanted his next four years to look like. He was fifty-eight, he had been running the company since he was thirty-one, and when he was honest with himself he did not want a board. He took the strategic offer, at a lower headline number, and he has never once described it to me as leaving money on the table. He would have been right to take the other one too, for a different reason. The mistake is not picking either. The mistake is comparing the two numbers without knowing what each one is made of.
If you are twelve to eighteen months out, the work is to figure out which lane your business actually sits in, confirm whether a real strategic case exists, and then prepare against that specific underwriting model rather than a generic one. That is the core of the preparation work we run at Cordis Group, and it is worth more than any single negotiated term, because it determines which room you end up standing in.